Skip to main content

Marisol Ruiz Meana

I have a degree in Veterinary Medicine and a Master's degree in Biochemistry from the Autonomous University of Barcelona. I obtained my PhD at the VHIR Cardiovascular Diseases’ group under the supervisión of Prof. David Garcia-Dorado on the mechanisms of cell death during myocardial ischemia-reperfusion. I am currently Principal Investigator of the group and since 2019 I have assumed the coordination of the laboratory. I’m a professor of the Master's Degree in Translational Biomedical Research at VHIR and have supervised 5 doctoral theses in the last years. I have an H index of 42.

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Marisol Ruiz Meana

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

I have a degree in Veterinary Medicine and a Master's degree in Biochemistry from the Autonomous University of Barcelona. I obtained my PhD at the VHIR Cardiovascular Diseases’ group under the supervisión of Prof. David Garcia-Dorado on the mechanisms of cell death during myocardial ischemia-reperfusion. I am currently Principal Investigator of the group and since 2019 I have assumed the coordination of the laboratory. I’m a professor of the Master's Degree in Translational Biomedical Research at VHIR and have supervised 5 doctoral theses in the last years. I have an H index of 42.

I have been dedicated to cardiovascular research since 1993, when I began my doctoral thesis under the direction of Dr. Garcia-Dorado, in the laboratory of Cardiovascular Diseases of the Vall d'Hebron Hospital. I completed my training with an international stay in the physiology laboratory of Prof. Hans Michael Piper, at the University of Dusseldorf, which allowed me to learn the model of isolated adult cardiomyocytes (we were pioneers in our country), one of the fundamental pillars of our research, and become familiar with (ratio)fluorescence imaging techniques for real-time quantification of intracellular ionic changes in cardiomyocytes. Since then, I have specialized in studies of cell biology and mitochondrial pathophysiology within the field of cardioprotection, mainly in the context of myocardial infarction. In recent years I have focused my interest on research into the mechanisms of aging and its impact on cardiomyocyte dysfunction, alterations in the interorganelle communication between the sarcoplasmic reticulum and mitochondria, and the accumulation of advanced glycation products as triggers of cell senescence.
Our research group, integrated within the Cardiology Service directed by Dr. Ignacio Ferreira, has been recognized as a Consolidated Research Group by the Generalitat of Catalonia and belongs to the Spanish network CIBER-CV. I am currently Principal Investigator of two projects on cardiovascular aging financed by the Instituto de Salud Carlos III and the Spanish Society of Cardiology, and I’m the vice-chair of a COST action financed by the European Union that brings together researchers from more than 35 countries with a common scientific interest in heart failure (EU-COST METAHEART).
My teaching activity includes the training of postgraduate students as a professor and coordinator of the Cardiovascular Diseases module of the Master in Translational Biomedical Research at the VHIR, and the training of doctoral students. I have been a member of the Internal Scientific Committee of my institution since 2018.

Projects

EU-METAHEART: EUropean network to tackle METAbolic alterations in HEART failure

IP: Marisol Ruiz Meana
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding:
Reference: EC / COST-ACTION / 2022 /RUIZ-MEANA
Duration: 18/10/2023 - 17/10/2027

MARCAJE RADIOACTIVO DE LOS CANALES TRPV4 COMO NUEVA HERRAMIENTA DE DIAGNÓSTICO DE LA FIBROSIS CARDÍACA

IP: Begoña Benito Villabriga
Collaborators: Ignacio Ferreira González, Nuria Rivas Gandara, Antonio Rodríguez Sinovas, Laia Yañez Bisbe, José Raul Herance Camacho, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: -Sociedad Española de Cardiologia
Funding: 14951.97
Reference: SEC/FEC-INV-BAS 23/26
Duration: 26/10/2023 - 31/12/2026

TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas

IP: Begoña Benito Villabriga
Collaborators: Carmen Escudero Iriarte, Ventura i Expósito, Laia, Susana Otero Romero, Ibane Abasolo Olaortua, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, María Rosario Pérez- Torres Lobato, Sunny Malhotra Sareen, Perez Dueñas, Belen, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Joaquin Seras Franzoso, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Julia German Cortes, Maria Jose Pérez García, Miguel Segura Ginard, Diego Baranda Martínez-Abasca, Cristina Auger Acosta, Neus Bellera Gotarda, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno García del Blanco, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Xavier Montalban Gairín, Simon Schwartz Navarro, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Angels Alcina Mila, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Ana Zabalza de Torres, Ariadna Boloix Amenós, Marc Miquel Moltó Abad, Javier Inserte Igual, Luciana Midaglia Fernandez, Elizabeth Pando Rau, Gabriela Guillén Burrieza, Cazurro Gutierrez, Ana Laura, Gómez Andrés, David, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lydia Dux-Santoy Hurtado, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Nicolás Miguel Fissolo, Maria Nazarena Pizzi, Tian Tian, Bou Teen, Diana, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Andrea Guala
Funding agency: Instituto de Salud Carlos III
Funding: 2494527.53
Reference: FORT23/00034
Duration: 01/01/2024 - 31/12/2027

Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento.

IP: Marisol Ruiz Meana
Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas, Bou Teen, Diana
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI22/00513
Duration: 01/01/2023 - 31/12/2025

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Borja González Rodríguez

Borja González Rodríguez

Reconstructive Surgery of the Locomotor System
Read more
Joana Rita Marques Soares

Joana Rita Marques Soares

Predoctoral researcher
Systemic Diseases
Read more
Maria Pilar Redondo Gonzalez

Maria Pilar Redondo Gonzalez

Research assistant
Microbiology
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.